These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23483055)

  • 1. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
    Desmet CJ; Gallenne T; Prieur A; Reyal F; Visser NL; Wittner BS; Smit MA; Geiger TR; Laoukili J; Iskit S; Rodenko B; Zwart W; Evers B; Horlings H; Ajouaou A; Zevenhoven J; van Vliet M; Ramaswamy S; Wessels LF; Peeper DS
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5139-44. PubMed ID: 23483055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
    Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
    Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
    Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
    Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
    Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
    Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
    Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival.
    Iskit S; Schlicker A; Wessels L; Peeper DS
    Oncotarget; 2015 Dec; 6(41):43146-61. PubMed ID: 26646695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation.
    Shu L; Chen A; Li L; Yao L; He Y; Xu J; Gu W; Li Q; Wang K; Zhang T; Liu G
    Oncogene; 2022 Feb; 41(6):907-919. PubMed ID: 34992218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.
    Chen GL; Li R; Chen XX; Wang J; Cao S; Song R; Zhao MC; Li LM; Hannemmann N; Schett G; Qian C; Bozec A
    Cell Death Differ; 2021 Apr; 28(4):1364-1378. PubMed ID: 33188281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine Receptor A2B Antagonist Inhibits the Metastasis of Gastric Cancer Cells and Enhances the Efficacy of Cisplatin.
    Wang H; Tan F; Xu Y; Ma Y; Li Y; Xiao H
    Technol Cancer Res Treat; 2023; 22():15330338221150318. PubMed ID: 36786018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
    Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
    Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.
    Luo YP; Zhou H; Krueger J; Kaplan C; Liao D; Markowitz D; Liu C; Chen T; Chuang TH; Xiang R; Reisfeld RA
    Oncogene; 2010 Feb; 29(5):662-73. PubMed ID: 19966854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy.
    Lu D; Chen S; Tan X; Li N; Liu C; Li Z; Liu Z; Stupack DG; Reisfeld RA; Xiang R
    Cancer Res; 2012 Jul; 72(14):3451-6. PubMed ID: 22586064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer.
    Moquet-Torcy G; Tolza C; Piechaczyk M; Jariel-Encontre I
    Nucleic Acids Res; 2014; 42(17):11011-24. PubMed ID: 25200076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer.
    Arnold S; Kortland J; Maltseva DV; Nersisyan SA; Samatov TR; Lezius S; Tonevitsky AG; Milde-Langosch K; Wicklein D; Schumacher U; Stürken C
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1525-1542. PubMed ID: 34693476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
    Motrich RD; Castro GM; Caputto BL
    PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
    Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
    Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y
    Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity.
    Nakajima H; Mizuta N; Sakaguchi K; Fujiwara I; Mizuta M; Furukawa C; Chang YC; Magae J
    J Antibiot (Tokyo); 2007 Nov; 60(11):682-9. PubMed ID: 18057697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
    Adiseshaiah P; Lindner DJ; Kalvakolanu DV; Reddy SP
    Cancer Res; 2007 Jul; 67(13):6204-11. PubMed ID: 17616677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.